Bank of America Lowers Cencora (NYSE:COR) Price Target to $360.00

Cencora (NYSE:COR) had its price target reduced by Bank of America from $380.00 to $360.00 in a report released on Monday,Benzinga reports. The firm currently has a “neutral” rating on the stock. Bank of America‘s target price suggests a potential upside of 4.05% from the stock’s previous close.

Several other equities analysts also recently issued reports on COR. TD Cowen upped their price objective on shares of Cencora from $350.00 to $400.00 and gave the company a “buy” rating in a research note on Monday, November 10th. Robert W. Baird set a $392.00 price objective on shares of Cencora in a research note on Tuesday, December 16th. Wall Street Zen cut Cencora from a “buy” rating to a “hold” rating in a research report on Friday, November 28th. UBS Group boosted their target price on Cencora from $380.00 to $415.00 and gave the company a “buy” rating in a report on Friday, November 7th. Finally, Wells Fargo & Company upped their price objective on shares of Cencora from $354.00 to $405.00 and gave the stock an “overweight” rating in a research report on Tuesday, November 11th. One investment analyst has rated the stock with a Strong Buy rating, eight have issued a Buy rating and four have assigned a Hold rating to the stock. According to data from MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and a consensus target price of $379.50.

Cencora Trading Up 1.5%

COR opened at $345.99 on Monday. The firm has a market cap of $67.12 billion, a P/E ratio of 43.52, a P/E/G ratio of 1.62 and a beta of 0.66. The company has a quick ratio of 0.55, a current ratio of 0.90 and a debt-to-equity ratio of 4.32. The business has a fifty day simple moving average of $349.89 and a 200-day simple moving average of $317.52. Cencora has a 52 week low of $229.36 and a 52 week high of $377.54.

Cencora (NYSE:COR) last announced its quarterly earnings data on Wednesday, November 5th. The company reported $3.84 earnings per share for the quarter, beating analysts’ consensus estimates of $3.79 by $0.05. Cencora had a net margin of 0.48% and a return on equity of 227.15%. The firm had revenue of $83.73 billion during the quarter, compared to analysts’ expectations of $83.36 billion. During the same quarter in the previous year, the business posted $3.34 earnings per share. The business’s quarterly revenue was up 5.9% compared to the same quarter last year. Cencora has set its FY 2026 guidance at 17.450-17.75 EPS. On average, equities analysts expect that Cencora will post 15.37 earnings per share for the current year.

Insiders Place Their Bets

In other news, EVP Elizabeth S. Campbell sold 3,351 shares of the firm’s stock in a transaction dated Friday, December 19th. The stock was sold at an average price of $342.10, for a total value of $1,146,377.10. Following the transaction, the executive vice president directly owned 23,891 shares in the company, valued at $8,173,111.10. This trade represents a 12.30% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, EVP Silvana Battaglia sold 1,677 shares of Cencora stock in a transaction dated Friday, December 19th. The shares were sold at an average price of $345.00, for a total value of $578,565.00. Following the completion of the transaction, the executive vice president directly owned 18,796 shares in the company, valued at $6,484,620. This represents a 8.19% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. In the last three months, insiders sold 20,317 shares of company stock valued at $7,009,260. Company insiders own 10.80% of the company’s stock.

Institutional Trading of Cencora

Several large investors have recently added to or reduced their stakes in COR. Atlantic Edge Private Wealth Management LLC raised its stake in shares of Cencora by 70.0% during the second quarter. Atlantic Edge Private Wealth Management LLC now owns 85 shares of the company’s stock valued at $25,000 after purchasing an additional 35 shares during the period. IAG Wealth Partners LLC acquired a new position in shares of Cencora in the 3rd quarter valued at approximately $30,000. Cloud Capital Management LLC acquired a new stake in shares of Cencora during the third quarter worth approximately $31,000. Caitlin John LLC acquired a new position in Cencora during the 3rd quarter worth $31,000. Finally, Vermillion & White Wealth Management Group LLC increased its position in shares of Cencora by 69.4% in the 2nd quarter. Vermillion & White Wealth Management Group LLC now owns 105 shares of the company’s stock worth $31,000 after purchasing an additional 43 shares during the last quarter. 97.52% of the stock is currently owned by institutional investors and hedge funds.

Cencora Company Profile

Cencora (NYSE:COR) is a global healthcare services and pharmaceutical distribution company that provides end-to-end solutions across the pharmaceutical supply chain. The company’s core activities include wholesale drug distribution, specialty drug distribution, and the operation of specialty pharmacies, complemented by logistics, cold-chain management and other fulfillment services designed to support complex and temperature-sensitive therapies.

Beyond physical distribution, Cencora offers a range of commercial and patient-focused services for pharmaceutical manufacturers and healthcare providers.